Learn topic
Deep Dive
Long-form explainers covering mechanism, evidence quality, and clinical context for individual peptides and peptide classes.
26 articles in this topic
Tirzepatide for Weight Loss: What the Clinical Trials Actually Show
Tirzepatide delivered 20.2% body weight reduction in the SURMOUNT-5 head-to-head trial against semaglutide — the largest weight loss ever recorded for a GLP-1 class drug. This guide covers every major trial, the dosing escalation schedule, side effects, cost, and who should consider it.
Peptides for Women: Safety, Benefits, and What’s Different
Women metabolize peptides differently than men — hormonal cycles, body composition, and reproductive considerations all matter. This guide covers what the research actually shows about peptides in women, from GLP-1 agonists and fertility to PT-141 and growth hormone secretagogues.
The Complete History of the FDA Peptide Crackdown
The FDA's regulatory campaign against peptides has fundamentally reshaped access, pricing, and clinical research. We trace the timeline from initial enforcement actions through recent category 2 bulk drug designations.
Compounding Pharmacy Regulation: What Changed and What It Means for Peptides
Compounding pharmacy regulation fundamentally shapes peptide accessibility. Understanding 503A vs 503B frameworks, Category 2 designations, and state-level variation is critical for clinicians and patients navigating legal peptide access.
The GLP-1 Market: How Semaglutide and Tirzepatide Created a $50B Industry
The GLP-1 receptor agonist market has become the fastest-growing pharmaceutical category in decades. We analyze the market dynamics, competitive landscape, and emerging pipeline that is reshaping obesity and diabetes therapeutics.
Peptide Research Funding: Who Is Paying for Clinical Trials?
Peptide research funding reflects broader pharmaceutical industry economics. We examine who funds clinical trials, why certain peptides remain unstudied, and how financial incentives shape which peptides advance to human investigation.
WADA, Sports, and Peptides: The Complete Anti-Doping Guide
Peptides represent a significant anti-doping challenge in elite sports. This guide covers WADA prohibitions, detection technologies, and athlete implications from growth hormone secretagogues to BPC-157 status.
Telehealth Peptide Prescriptions: How Online Clinics Are Changing Access
Online telehealth clinics have become primary access pathways for peptide prescriptions. We analyze the regulatory landscape, cost structures, quality control gaps, and patient safety implications of this distributed model.
Insurance Coverage for Peptide Therapy: A State-by-State Analysis
Insurance coverage fundamentally determines peptide therapy accessibility. This analysis examines which peptides are covered, state-level variation, prior authorization requirements, and coverage gaps affecting millions of patients.
How Peptides Are Manufactured: From Lab Synthesis to Clinical Grade
Peptide manufacturing complexity directly impacts clinical safety and efficacy. This deep dive examines synthesis methods, quality assurance, manufacturing standards, and supply chain risks from raw material to final product.
International Peptide Regulation: US vs EU vs Australia vs Russia
Peptide regulation varies dramatically across international jurisdictions, creating different access patterns and therapeutic availability. We analyze how US, EU, Australian, and Russian regulatory approaches differ and what those differences mean for researchers and patients.
The Science of Peptide Stability: Storage, Reconstitution, and Degradation
Peptides are fragile molecules susceptible to degradation through oxidation, hydrolysis, and protein aggregation. Understanding peptide stability science is critical for therapeutic efficacy and safety. This guide covers storage requirements, reconstitution protocols, and degradation detection.
Are Peptides Safe? Side Effects, Risks & What the Evidence Shows
Peptides are surging in popularity, but safety information is scattered between promotional hype and fearmongering. This evidence-based guide covers what clinical research actually shows about peptide side effects, contamination risks, and how to evaluate safety for specific compounds.
Best Peptides for Muscle Growth & Recovery: What the Research Shows
Which peptides actually have evidence for muscle growth and recovery? We reviewed the clinical research on growth hormone secretagogues, healing peptides, and collagen peptides to separate proven results from gym-floor hype.
Best Peptides for Anti-Aging & Longevity: What the Evidence Actually Shows
Anti-aging peptide shots are trending on social media and in longevity clinics. But which peptides actually have human evidence for aging-related outcomes? We reviewed the research on every major anti-aging peptide to separate the science from the marketing.
Peptides for Hair Growth & Hair Loss: What the Research Actually Shows
Searches for "peptides for hair growth" surged in early 2026 as mainstream outlets from Yahoo Finance to Who What Wear covered the trend. But which peptides actually have human evidence for hair regrowth? We reviewed the science behind every major hair-loss peptide.
Peptides for Gut Health & IBS: Evidence Review 2026
BPC-157 has dominated gut health research, but most evidence comes from animal models. We examine what we actually know about peptides for IBS, leaky gut, and intestinal healing.
Peptides for Sleep & Recovery: Clinical Evidence 2026
DSIP (delta sleep-inducing peptide) originated in Soviet-era sleep research. We examine what the evidence actually shows — and what methodological concerns apply.
Peptides for Cognitive Function & Brain Health: Evidence Review 2026
Most nootropic peptide research comes from Russian scientists. We examine what the evidence shows — and what Western replication tells us.
Anti-Inflammatory Peptides: Evidence-Based Review 2026
Inflammation is central to aging and disease. We examine which peptides have evidence for anti-inflammatory effects — and which claims overreach the data.
GHK-Cu: Why This Copper Peptide Is the Fastest-Growing Peptide Search of 2026
Search interest in GHK-Cu has grown over 1,000% year-over-year, making it the fastest-growing peptide query of 2026. Here is the research driving the trend and what the evidence actually supports.
How AI Is Revolutionizing Peptide Drug Discovery in 2026
Artificial intelligence is compressing peptide drug discovery timelines from 10-15 years to months. Here's how machine learning, generative models, and structure prediction are transforming the future of peptide therapeutics.
Are Injectable Peptides Safe for Anti-Aging? What the Evidence Actually Shows in 2026
Injectable peptides have gone from niche biohacker protocol to mainstream wellness trend. BPC-157, TB-500, GHK-Cu, and others are marketed for anti-aging, healing, and performance. But what does the human safety evidence actually show?
Do Peptides Build Muscle? What the Science Actually Says in 2026
Peptides are marketed as muscle-building shortcuts, but the science tells a more nuanced story. Here is what controlled studies actually show about peptides, growth hormone, and muscle growth — and what remains unproven hype.
NAD+ and MOTS-c: What the Longevity Peptide Research Actually Shows in 2026
NAD+ and MOTS-c are two of the most searched longevity compounds in 2026. Here is what the clinical evidence actually shows — and where the gap between marketing claims and published data is widest.
GLP-1 Drugs and Addiction: Could Ozempic Treat Substance Use Disorders?
A growing body of evidence suggests GLP-1 drugs like semaglutide may reduce substance use and addiction. A 2026 veterans study found 50% fewer substance-use deaths among GLP-1 users. Here is what the science shows and what trials are underway.